MOH — authorised 5 March 1991
- Marketing authorisation holder: BERLEX LABS
- Status: likely_approved
MOH authorised Leukine on 5 March 1991
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 5 March 1991.
BERLEX LABS holds the UAE marketing authorisation.